AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% and HYPERSENSITIVITY

3 reports of this reaction

1.6% of all AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% reports

#14 most reported adverse reaction

Overview

HYPERSENSITIVITY is the #14 most commonly reported adverse reaction for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, manufactured by Beiersdorf Inc. There are 3 FDA adverse event reports linking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% to HYPERSENSITIVITY. This represents approximately 1.6% of all 183 adverse event reports for this drug.

Patients taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% who experience hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HYPERSENSITIVITY3 of 183 reports

HYPERSENSITIVITY is a less commonly reported adverse event for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, but still significant enough to appear in the safety profile.

Other Side Effects of AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%

In addition to hypersensitivity, the following adverse reactions have been reported for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%:

Other Drugs Associated with HYPERSENSITIVITY

The following drugs have also been linked to hypersensitivity in FDA adverse event reports:

ABACAVIR SULFATEABATACEPTACETAMINOPHEN AND IBUPROFENACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, IBUPROFENADAPALENEADAPALENE AND BENZOYL PEROXIDE.ALPHA. TOCOPHEROL ACETATE, DL , ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN DALUMINUM SESQUICHLOROHYDRATEALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLYALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYAPREPITANTARNICA MONTANAAVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENEAVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENEAVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONEAVOBENZONE, OCTISALATE, AND OCTOCRYLENEBACITRACIN ZINC AND POLYMYXIN B SULFATEBENRALIZUMABBENZETHONIUM CHLORIDE

Frequently Asked Questions

Does AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% cause HYPERSENSITIVITY?

HYPERSENSITIVITY has been reported as an adverse event in 3 FDA reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HYPERSENSITIVITY with AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

HYPERSENSITIVITY accounts for approximately 1.6% of all adverse event reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, making it a notable side effect.

What should I do if I experience HYPERSENSITIVITY while taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

If you experience hypersensitivity while taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% Full ProfileAll Drugs Causing HYPERSENSITIVITYBeiersdorf Inc Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.